DEC 02, 2016 05:30 AM PST

Early Skin Cancer May be Treatable with New Topical Cream

WRITTEN BY: Xuan Pham
Good news for patients with early stage skin cancer: a combination drug seems to be effective at attacking the skin cancer cells. And on top of that, the drug combo can be applied topically. Furthermore, because the drugs have already been approved and prescribed for years, thiscould significantly shorten the time before this new drug combo makes it to the market.


The drug is a combination of 5-fluorouracil, a common chemotherapy drug, and calcipotriol, a synthetic version of vitamin D. Both drugs are already approved for the treatment of skin-related conditions: 5-fluorouracil is prescribed for patients with actinic keratinosis, and calcipotriol treats psoriasis.
 
But together is better. In a trial, researchers found that the combination drug reduced the number of precancerous lesions on the face by 88 percent. By contrast, chemotherapy alone showed only a 26 percent reduction.
 
Of note, the drug is effective against early skin cancer known as actinic keratinosis. Untreated, this type of precancer evolves into squamous cell carcinoma, a fully dangerous skin cancer.
 
"We looked at precancerous lesions on patients with sun-damaged skin," said Washington University dermatologist and study co-author Lynn A. Cornelius, MD, director of the Division of Dermatology. "Most commonly found on the face, scalp and arms, these lesions appear abnormal by visual examination and under the microscope but are not full-blown skin cancers. But because these lesions have the potential to develop into a true skin cancer, they are commonly treated. Our study shows this combination therapy is more effective and better tolerated than current treatment practices."
 
The ease of application for this new chemo combo is unparalleled. The cream, applied topically on the skin, appears to boost the immune response. This sends more T cells to attack the abnormal cells at the precancerous lesions.
 

"The idea behind this study was to induce a heightened immune response in the skin using calcipotriol combined with the 5-fluorouracil that works to destroy the precancerous cells," Cornelius said. "In so doing, the destroyed precancerous cells release cell proteins, or antigens, and facilitate the heightened immune system to respond. We compared the two-drug formulation to 5-fluorouracil alone over a shorter application period -- four days as opposed to two to four weeks that is typical for the standard treatment of 5-fluorouracil alone."
 
"Because calcipotriol has been shown to induce an immune response, we are now interested in seeing if the anti-tumor immunity of the activated T cells can be recalled later to help prevent both precancerous and cancerous skin lesions," Cornelius said. "We are now planning to re-contact our patients to determine whether there are differences in precancerous and skin cancer rates between the two treatment groups."

Additional source: Washington University in St. Louis
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 10, 2018
Cancer
JUL 10, 2018
New Potential Inhibitor Target for Mantle Cell Lymphoma
A new small molecule inhibitor, called PTC596, initiated apoptosis in MCL cells according to a study published this month in Oncotarget....
AUG 07, 2018
Cancer
AUG 07, 2018
Renal Cell Carcinoma and Myelodysplastic Syndrome Show Epigenetic Association
DNA methylation patterns in renal cell carcinoma (RCC) have a strong association with myelodysplastic syndrome DNA hypermethylation later in life....
AUG 15, 2018
Cancer
AUG 15, 2018
Cancer Control Headway in The Last 20 Years
Learning from history and what changes have been made will continue to help drive cancer controls for the future....
SEP 26, 2018
Videos
SEP 26, 2018
Cancer Immunotherapy
Video illustration about how tumor cells are sensed and destroyed by the immune system and how tumors evolve and detect immune-mediated eliminations, as well as iimmunotherapies associated....
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
OCT 07, 2018
Videos
OCT 07, 2018
Certain Foods Encourage a Gut Microbe, and Colon Cancer
Researchers reveal more evidence that refined grains and sugars and processed meats are bad for colon health....
Loading Comments...